Veterinary Regulatory
Regulation, Quality, and ResponsibilityClear Guidance for a Complex, Underserved Market
Veterinary medical products occupy a unique and often misunderstood regulatory space. They sit at the intersection of medical devices, pharmaceuticals, biologics, and enforcement discretion – yet they are frequently treated as if no regulatory or quality expectations apply at all.
That assumption creates risk.
Medical Devices and Pharma (MDP) provides clear, practical regulatory and quality guidance for companies developing, manufacturing, importing, or marketing veterinary medical products in the United States and internationally.
We help organizations understand which regulatory requirements apply, which does not, and how to build right-sized, defensible systems that protect animals, customers, and businesses alike.
Why Veterinary Regulation Is Different – and Why It Still Matters
Unlike human medical devices, many veterinary products do not follow a single, clearly defined FDA pathway.
Oversight may fall under FDA’s Center for Veterinary Medicine (CVM), the Center for Devices and Radiological Health (CDRH), or may operate under varying degrees of enforcement discretion.
This ambiguity leads to common – and costly – mistakes. Like assuming “veterinary use only” means no regulation. Importing or private labeling products without defined regulatory responsibility.
Making marketing claims that unintentionally trigger enforcement. And operating without documented quality controls until a problem occurs.
MDP helps veterinary manufacturers and brand owners navigate this complexity with risk-based, reality-tested advice, grounded in decades of experience with FDA-regulated industries.